TNF-α can activate anti-tumor immune responses, yet it can also facilitate immune suppression within the tumor microenvironment, adding to the ongoing controversy surrounding its overall impact on colon cancer pathophysiology [54,55]. The gene discussed is TNF; the disease is colonic neoplasm.